A study published in 2021 demonstrated that loss-of-function mutations in Hspd1 lead to a profound energetic collapse, which directly impairs the ability of cancer cells to proliferate and expand, thereby disrupting tumor progression [49]. This evidence concerns the gene HSPD1 and cancer.